- Report
- December 2025
- 262 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- October 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- April 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- April 2025
- 200 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- March 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- November 2025
- 187 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- August 2025
- 180 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- May 2025
- 186 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- April 2025
- 184 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- February 2025
- 185 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- February 2025
- 184 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- January 2025
- 182 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- August 2025
- 183 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- May 2025
- 185 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- October 2025
- 144 Pages
Global
From €2249EUR$2,549USD£1,969GBP
€2646EUR$2,999USD£2,317GBP
- Report
- March 2025
- 145 Pages
Global
From €2249EUR$2,549USD£1,969GBP
€2646EUR$2,999USD£2,317GBP
- Report
- November 2025
- 150 Pages
Global
From €2647EUR$3,000USD£2,318GBP
€3308EUR$3,750USD£2,897GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €882EUR$1,000USD£773GBP
€1103EUR$1,250USD£966GBP
- Report
- February 2025
- 221 Pages
Global
From €2206EUR$2,500USD£1,931GBP
- Report
- November 2025
- 145 Pages
Global
From €3485EUR$3,950USD£3,052GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more